Navigation Links
Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
Date:7/8/2008

to our current or planned products; whether we will encounter problems or delays in automating our processes; the ultimate validity and enforceability of our patent applications and patents; the possible infringement of the intellectual property of others; whether licenses to third party technology will be available; whether we are able to build brand loyalty and expand revenues; restrictions on the conduct of our business imposed by the Pfizer, Merrill Lynch and other debt agreements; the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to raise sufficient capital in the future, if required. For a discussion of other factors that may cause actual events to differ from those projected, please refer to our most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission. We do not undertake, and specifically disclaim any obligation, to revise any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements.

VeraTag and HERmark are trademarks of Monogram Biosciences, Inc. Herceptin is a registered trademark of Genentech, Inc.

Contacts: Alfred G. Merriweather Jeremiah Hall

Chief Financial Officer Feinstein Kean Healthcare

Tel: 650 624-4576 Tel: 415 677-2700

amerriweather@ jeremiah.hall@

monogrambio.com fkhealth.com


'/>"/>
SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
2. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
3. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
4. Monogram Announces First Medicare Payment for Trofile(TM)
5. The Center for Professional Innovation and Education (CfPIE) Announces the First True Certification Program for Document Management Professionals in the Life Sciences
6. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
7. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
8. NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast
9. Ventas Announces 2008 Second Quarter Earnings Release Date and Conference Call
10. QuikByte Software, Inc. Announces Changes to Board of Directors and Executive Ranks
11. March of Dimes Announces Nursing Scholarship Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 18, 2015 Rosetta Radiology is proud ... out their list of diagnostic imaging services. This solidifies ... on the Upper East Side of Manhattan. , The ... capacity. The addition of PET-CT, combined with Rosetta’s state ... ability to work with patients through several stages of ...
(Date:4/17/2015)... 17, 2015 Alcohol and Violence , ... notes that drinking and driving has been the focus ... same time, the link between alcohol and crime received ... and violence and sexual assault, and their relationship to ... NCADD, 5.3 million adults in America were drinking alcohol ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 From the day ... ago, the Texas non-profit organization has empowered young people to ... effort to bring fresh water and the Gospel to ... Liberty University. Between March 17 and 27, students, faculty and ... 7,000 Liberians with fresh water and the Good News of ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Representatives Jim ... Diagnoses and Treatment Act HR 1849 in congress on ... rates and treatment for patients with the genetic disease. ... the past, would be the first to create a ... appropriate treatment of hereditary hemorrhagic telangiectasia. This would effectively ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 At ... Entertainment’s EcoLuxe Lounge and the “Salute to the Oscars” ... luxurious Beverly Hilton Hotel, overlooking the impressive Los Angeles ... were organized by Debbie Durkin, LA’s leading producer of ... Showcasing many of the world’s premier providers of eco-friendly ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2
... Calif., Feb. 12 The Centers for Disease ... heart disease is America,s leading cause of death. ... a new heart-related coronary attack, and about 470,000 ... American Heart Month, thousands of people nationwide focus ...
... West Pharmaceutical Services, Inc. (NYSE: WST ... quarter financial results before the market opens on Thursday, ... call to discuss the results and business expectations at ... please dial (888)790-3758 or (210)839-8398. The passcode is WST.A ...
... results -LAVAL, QC, Feb. 12 /PRNewswire-FirstCall/ - Labopharm Inc. ... that it will host a conference call on Thursday, ... fourth quarter 2008 financial results. Labopharm will report its ... approximately 7:00 a.m. the same day. , To access ...
... Health Coordinates North Benin Screening , ... Cotonou, Benin, ... hospital ship, the Africa Mercy, docked in Cotounou, Benin , ... nation,s Ministry of Health. , , , , ,The hospital ...
... referred to as ,male menopause, may not be a ... depression, it is estimated that four out of five ... Since 1999, re NEW MAN (renewman.com) has been renowned ... self administered testosterone and HGH (human growth hormone) treatments. ...
... Portola to Receive $75 Million Upfront Cash ... Plus Royalties on Future Sales --SOUTH SAN ... Inc., a privately-held biopharmaceutical company developing innovative ... disease, inflammatory disease and cancer, today announced ...
Cached Medicine News:Health News:The ISSA Offers 8 Tips for American Heart Month 2Health News:West to Host 2008 Fourth Quarter Conference Call 2Health News:Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET) 2Health News:Mercy Ship Arrives in Benin 2Health News:Mercy Ship Arrives in Benin 3Health News:Male Hormone Replacement Therapy Optimism for 2009 2Health News:Male Hormone Replacement Therapy Optimism for 2009 3Health News:Male Hormone Replacement Therapy Optimism for 2009 4Health News:Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel 2Health News:Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel 3
(Date:4/17/2015)... Inivata, a Cambridge, England -based ... the 2015 American Association for Cancer Research (AACR) Annual Meeting ... and a poster presentation. Michael Stocum , CEO ... nd . The presentation, entitled Monitoring the ... part of a session on Recent Advances in Diagnostics ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) ... - Global Strategic Business Report" report to their ... for ADME-Toxicology Testing in US$ Million by the following ... The report provides separate comprehensive analytics for ... Japan , Europe , ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/vrd3bd/mammography ) has announced ... Strategic Business Report" report to their offering. ... Equipment in US$ Thousands by the following Product Segments: ... provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ...
Breaking Medicine Technology:Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2
... Inc. (Nasdaq: TRBN ) today announced financial results ... 30, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ) , ... , Revenue for the third quarter and nine ... $12.8 million, respectively, compared with $3.8 million and $12.2 ...
... Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at ... on Wednesday, November 11, 2009 at 10:00 a.m. PT / ... finance and chief financial officer at Amylin Pharmaceuticals, will be ... presentation will be webcast and a recording will be made ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 2Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 3Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 4Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 5Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 6Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 7
Opti-One multi-purpose solution with citrate protein removal and advanced surfactant combination....
Light weight adjustable trial frame, adult...
Classic Trial Frames UB3 that has long set the standard....
Non Sterile surgical blade....
Medicine Products: